Lunai Bioworks cuts CEO base salary to $275K
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lunai Bioworks, Inc. (LNAI) amended and restated its employment agreement with David Weinstein, its chief executive officer and a director, effective October 14, 2026. His annual base salary is $275,000, reduced from $400,000 under the prior agreement, and he is not entitled to a bonus or equity award unless separately approved by the board. His at-will employment ends December 28, 2026, unless extended in writing.
The agreement defers $28,150.68 of October 2026 salary, payable without interest in a lump sum by the earlier of the end of employment and December 28, 2026, and in all events no later than March 15, 2027. Weinstein waived prior severance of six months’ base salary (approximately $200,000), continued benefits and accelerated vesting for termination without Cause or for Good Reason. Separately, LNAI’s Nasdaq delisting is expected on or about November 12, 2026; withdrawal of its Section 12(b) registration becomes effective 90 days after the November 2, 2026 Form 25 filing.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- None.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.Nasdaq delisting is expected on or about November 12, 2026.
Filing Explained
The amendment ends Weinstein’s non-compete and non-solicitation duties, while confidentiality and invention-assignment obligations continue.
The company entered into the amended agreement on
It also preserves Weinstein’s indemnification, expense-advancement, and directors’ and officers’ insurance rights.
8-K Event Classification
Key Figures
Key Terms
at will technical
Good Reason technical
accelerated vesting financial
Form 25 regulatory
Section 12(b) regulatory
invention-assignment obligations technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is David Weinstein’s salary under the LNAI agreement?
When is LNAI expected to delist from Nasdaq?
When will LNAI pay David Weinstein’s deferred October salary?
AI-generated analysis. How Rhea-AI works. Not financial advice.